Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2025, Vol. 30 ›› Issue (1): 20-31.doi: 10.12092/j.issn.1009-2501.2025.01.003

Previous Articles     Next Articles

Study on the mechanism of pinoresinol diglucoside on angiogenesis during osteoporotic fracture healing

WANG Jie, TIAN Shuo, LI Yilin, WEI Jun, MA Yu, LIU Yanqiu   

  1. School of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan 250355, Shandong, China
  • Received:2024-01-24 Revised:2024-03-22 Online:2025-01-26 Published:2025-01-02

Abstract:

AIM: To explore the regulatory mechanism of pinoresinol diglucoside (PDG) on angiogenesis during osteoporotic fracture healing in vivo and in vitro. METHODS: Fifty male C57BL/6J mice were randomly divided into five groups: normal group, model group, PDG 0.005, 0.015 g/kg groups, and parathyroid hormone 1-34 (PTH1-34) 4×10-5 g/kg group. The osteoporotic fracture model of ovariectomized combined with femoral fracture was established, the PDG group was given intragastric administration every other day and the PTH1-34 group was given subcutaneous injection of PTH1-34 every other day for 8 weeks. Micro-CT scanning, immunofluorescence and immunohistochemical staining were used to detect the related parameters and protein expressions. Human umbilical vein endothelial cells (HUVECs) were cultured, normal group, PDG 1, 10, 100 μmol/L groups and PTH1-34 1 ng/mL group were set up. CCK-8 assay, scratch experiment, tubule formation experiment, immunofluorescence and Western blot were used to detect the related parameters and protein expressions. RESULTS: In vivo experiments found, compared with the normal control group, a small amount of bone callus volume of fracture site were increased in the model control group, while BMD of non-callus site of femur, trabecular bone fraction (BV/TV), trabecular thickness (Tb. Th) and trabecular number (Tb. N) were decreased (P<0.01), and trabecular separation (Tb. Sp) was increased (P<0.01). The positive expression of vascular endothelial marker vascular endothelial markers (CD31) was decreased (P<0.01). Compared with mice in the model control group, bone callus volume, index of BMD and BV/TV were increased in the PDG 0.005 g/kg group (P<0.05), index of BMD, BV/TV, Tb. Th, Tb. N were increased, and index of Tb. Sp was decreased in the PDG 0.015 g/kg group (P<0.05), the positive expression of CD31 was increased in the PDG administration groups (P<0.01), the protein expressions of vascular endothelial growth factor (VEGF-A) (P<0.01), Yes-associated protein 1 (YAP1) (P<0.01), PDZ-binding motif (TAZ) (P<0.05) and TEA domain transcription factor 2 (TEAD2) (P<0.01) were increased in callus in the PDG 0.015 g/kg groups. Cell experiments found, compared with the normal control group, PDG groups promoted the proliferation, migration and tubule formation activity of HUVECs to varying degrees (P<0.05), at the same time, the expression of endothelial cadherin (E-cadherin) was decreased (P<0.01), and VEGF-A, TEAD2, TAZ and YAP1 protein expression were increased (P<0.05). CONCLUSION: PDG may accelerate osteoporotic fracture healing by promoting bone angiogenesis through regulating Hippo signal pathway.

Key words: pinoresinol diglucoside, osteoporotic fracture, osteogenesis, angiogenesis, vascular endothelial cells

CLC Number: